Retinoblastoma: Concerning its initiation and treatment

International Journal of Ophthalmology

Volumn 6, Issue 3, 2013, Pages 397-401

  Luo, Chang ^a   Deng, Ying Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Epidemiology; Leukocoria; Medical management; Retinoblastoma; Retinoblastomal gene

Indexed keywords

EID: 84894561294     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2013.03.26     Document Type: Review

References (42)

1. Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009; 93(9): 1129-1131.
2. Comings DE. A general theory of carcinogenesis. Proc Natl Acad Sci USA. 1973; 70(12): 3324-3328.
3. Friend SH, Bernards R, Rogelj S., Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DN A segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986; 323(6089): 643-646.
4. Knudson AG., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971; 68(4): 820-823.
5. Dimaras H, Kimani K, Dimba E.A., Gronsdahl P., White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012; 379(9824): 1436-1446.
6. Menon BS, Alagaratnam J, Juraida E., Mohamed M, Ibrahim H, Naing NN. Late presentation of retinoblastoma in Malaysia. Pediatr Blood Cancer. 2009; 52(2): 215-217.
7. Bowman RJ, Mafwiri M, Luthert P., Luande J, Wood M. Outcome of retinoblastoma in east Africa. Pediatr Blood Cancer. 2008; 50(1): 160-162.
8. Abramson DH, Frank CM, Susman M, Whalen M.P., Dunkel IJ, Boyd NW., 3rd Presenting signs of retinoblastoma. J Pediatr. 1998; 132(3 Pt 1): 505-508.
9. Yun J, Li Y, Xu C.T., Pan BR. Epidemiology and Rb1 gene of retinoblastoma. Int J Ophthalmol. 2011; 4(1): 103-109.
10. MacCarthy A, Birch JM, Draper G.J., Hungerford JL, Kingston JE, Kroll ME, Onadim Z, Stiller C.A., Vincent TJ, Murphy MF. Retinoblastoma in Great Britain 1963-2002. Br J Ophthalmol. 2009; 93(1): 33-37.
11. MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42(13): 2092-2102.
12. Nyamori JM, Kimani K, Njuguna M.W., Dimaras H. The incidence and distribution of retinoblastoma in Kenya. Br J Ophthalmol. 2012; 96(1): 141-143.
13. Leal-Leal C., Flores-Rojo M, Medina-Sansón A, Cerecedo-Díaz F, Sánchez-Félix S, González-Ramella O, Pérez-Pérez F, Gómez-Martínez R, Quero-Hernández A, Altamirano-Alvarez E, Alejo-González F, Figueroa-Carbajal J, Ellis-Irigoyen A, Tejocote-Romero I, Cervantes-Paz R, Pantoja-Guillén F, Vega-Vega L, Carrete-Ramírez F. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004; 88(8): 1074-1077.
14. Rodrigues KE, Latorre Mdo R, de Camargo B. Delayed diagnosis in retinoblastoma. J Pediatr (Rio J) 2004; 80(6): 511-516.
15. Canadian Retinoblastoma Society National Retinoblastoma Strategy Canadian guidelines for care: stratégie thérapeutique du rétinoblastome guide clinique canadien. Can J Ophthalmol. 2009; 44(SUPPL. 2): S1-88.
16. Leander C, Fu LC, Peña A, Howard S.C., Rodriguez-Galindo C, Wilimas JA, Ribeiro R.C., Haik B. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer. 2007; 49(6): 817-819.
17. Dyer MA, Bremner R. The search for the retinoblastoma cell of origin. Nat Rev Cancer. 2005; 5(2): 91-101.
18. Sage J. The retinoblastoma tumor suppressor and stem cell biology. Genes Dev. 2012; 26(13): 1409-1420.
19. Flowers S, Beck GR, Jr, Moran E. Transcriptional activation by pRB and its coordination with SWI/SNF recruitment. Cancer Res. 2010; 70(21): 8282-8287.
20. van Harn T., Foijer F, van Vugt M, Banerjee R, Yang F., Oostra A, Joenje H, te Riele H. Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev. 2010; 24(13): 1377-1388.
21. Xu XL, Fang Y, Lee T.C., Forrest D., Gregory-Evans C, Almeida D, Liu A., Jhanwar SC, Abramson DH, Cobrinik D. Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell. 2009; 137(6): 1018-1031.
22. McEvoy J, Flores-Otero J, Zhang J., Nemeth K, Brennan R, Bradley C., Krafcik F, Rodriguez-Galindo C, Wilson M, Xiong S., Lozano G, Sage J, Fu L., Louhibi L, Trimarchi J, Pani A, Smeyne R, Johnson D, Dyer MA. Coexpression of normally incompatible developmental pathways in retinoblastoma genesis. Cancer Cell. 2011; 20(2): 260-275.
23. Ajioka I, Martins RA, Bayazitov I.T., Donovan S., Johnson DA, Frase S, Cicero SA, Boyd K, Zakharenko S.S., Dyer MA. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell. 2007; 131(2): 378-390.
24. Chen D, Livne-Bar I, Vanderluit J.L., Slack RS, Agochiya M, Bremner R. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell. 2004; 5(6): 539-551.
25. Hu N, Gutsmann A, Herbert D.C., Bradley A., Lee WH, Lee EY. Heterozygous Rb-1 delta 20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene. 1994; 9(4): 1021-1027.
26. MacPherson D, Sage J, Kim T., Ho D, McLaughlin ME, Jacks T. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev. 2004; 18(14): 1681-1694.
27. Sangwan M, McCurdy SR, Livne-Bar I, Ahmad M., Wrana JL, Chen D, Bremner R. Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation. Oncogene. 2012; 31(48): 5019-5028.
28. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet. 2000; 25(3): 338-342.
29. Christensen J, Agger K, Cloos P.A., Pasini D., Rose S, Sennels L, Rappsilber J., Hansen KH, Salcini AE, Helin K. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell. 2007; 128(6): 1063-1076.
30. Isaac CE, Francis SM, Martens A.L., Julian LM, Seifried LA, Erdmann N, Binné UK, Harrington L, Sicinski P, Bérubé NG, Dyson NJ, Dick FA. The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol. 2006; 26(9): 3659-3671.
31. Coschi CH, Martens AL, Ritchie K, Francis S.M., Chakrabarti S., Berube NG, Dick FA. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev. 2010; 24(13): 1351-1363.
32. Eng C, Li FP, Abramson D.H., Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N., Boice JD., Jr Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993; 85(14): 1121-1128.
33. Wong FL, Boice JD, Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF, Jr, Li FP. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997; 278(15): 1262-1267.
34. Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am. 2005; 18(1): 41-53.
35. Kivela T, Singh A. Information for authors project. 2011 http://eyecancerbig.com/EyeCaBIG/Journals-and-Societies.html.
36. Stallard HB. Irradiation of retinoblastoma. Lancet. 1952; 1(6717): 1046-1049.
37. Kleinerman RA, Tucker MA, Tarone R.E., Abramson DH, Seddon JM, Stovall M, Li F.P., Fraumeni JF., Jr Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005; 23(10): 2272-2279.
38. Fletcher O, Easton D, Anderson K., Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004; 96(5): 357-363.
39. Gobin YP, Dunkel IJ, Marr B.P., Brodie SE, Abramson DH. Intraarterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011; 129(6): 731-737.
40. Vajzovic LM, Murray TG, Aziz-Sultan MA, Schefler A.C., Wolfe SQ, Hess D, Fernandes CE, Dubovy SR. Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma. Clin Ophthalmol. 2011; 5: 171-176.
41. Abramson DH, Dunkel IJ, Brodie S.E., Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008; 115(8): 1398-1404.
42. Abramson DH, Dunkel IJ, Brodie S.E., Marr B., Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol. 2010; 128(3): 370-372.